Skip to main content
PMC home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1996 Oct;72(5):321–329. doi: 10.1136/sti.72.5.321

The role of epidemiology and surveillance systems in the control of sexually transmitted diseases.

M A Catchpole 1
PMCID: PMC1195697  PMID: 8976846

Abstract

Surveillance and epidemiological studies are essential components of effective control programmes for sexually transmitted diseases. While other forms of basic biomedical research may add to our understanding of why an exposure or behaviour causes or prevents disease, only epidemiology allows the quantification of the magnitude of the exposure-disease relationship in humans. It is this measure of the association between risk and disease that is needed to inform rational policy on altering risk through intervention. Surveillance data are used both to determine the need for public health action and to assess the effectiveness of programmes: they are required for the setting of priorities, for planning and resource allocation, for the definition of population subgroups and risky behaviours for targeted interventions, for the development of disease prevention programmes, and for the evaluation of interventions. Data from surveillance systems and epidemiological studies can also inform diagnostic and therapeutic practice, and indicate areas for further research. Over the last 20 years chlamydia infections and viral agents have emerged as the major cause of STD in developed countries, and with this change in the aetiological mix of STD cases the focus of prevention and control of STDs has shifted from treatment and partner notification towards health education. In developing countries there is an urgent need for appropriate surveillance infrastructures, particularly now that there is evidence that STD control programmes, informed by surveillance data, can reduce HIV transmission at the population level. The importance of surveillance and epidemiology in the control of STDs is set to increase in the face of the changing pattern of sexually transmitted pathogens. The challenge to clinicians and epidemiologists is to work together in developing systems that will inform new approaches to control and prevention.

Full text

PDF
326

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler M. W., Belsey E. M., Rogers J. S. Sexually transmitted diseases in a defined population of women. Br Med J (Clin Res Ed) 1981 Jul 4;283(6283):29–32. doi: 10.1136/bmj.283.6283.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bamber S. D., Hewison K. J., Underwood P. J. A history of sexually transmitted diseases in Thailand: policy and politics. Genitourin Med. 1993 Apr;69(2):148–157. doi: 10.1136/sti.69.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blackwell A. L., Thomas P. D., Wareham K., Emery S. J. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet. 1993 Jul 24;342(8865):206–210. doi: 10.1016/0140-6736(93)92299-9. [DOI] [PubMed] [Google Scholar]
  4. Bogaerts J., Vandepitte J., Van Dyck E., Vanhoof R., Dekegel M., Piot P. In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda. Genitourin Med. 1986 Aug;62(4):217–220. doi: 10.1136/sti.62.4.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown S. T., Zacarias F. R., Aral S. O. STD control in less developed countries: the time is now. Int J Epidemiol. 1985 Dec;14(4):505–509. doi: 10.1093/ije/14.4.505. [DOI] [PubMed] [Google Scholar]
  6. Brunham R. C. The concept of core and its relevance to the epidemiology and control of sexually transmitted diseases. Sex Transm Dis. 1991 Apr-Jun;18(2):67–68. doi: 10.1097/00007435-199118020-00001. [DOI] [PubMed] [Google Scholar]
  7. Clottey C., Dallabetta G. Sexually transmitted diseases and human immunodeficiency virus. Epidemiologic synergy? Infect Dis Clin North Am. 1993 Dec;7(4):753–770. [PubMed] [Google Scholar]
  8. Cowan F. M., Johnson A. M., Ashley R., Corey L., Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ. 1994 Nov 19;309(6965):1325–1329. doi: 10.1136/bmj.309.6965.1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cowan F. M., Mindel A. Sexually transmitted diseases in children: adolescents. Genitourin Med. 1993 Apr;69(2):141–147. doi: 10.1136/sti.69.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. D'Costa L. J., Plummer F. A., Bowmer I., Fransen L., Piot P., Ronald A. R., Nsanze H. Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis. 1985 Apr-Jun;12(2):64–67. doi: 10.1097/00007435-198504000-00002. [DOI] [PubMed] [Google Scholar]
  11. Day S., Ward H., Harris J. R. Prostitute women and public health. BMJ. 1988 Dec 17;297(6663):1585–1585. doi: 10.1136/bmj.297.6663.1585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dryden M. S., Wilkinson M., Redman M., Millar M. R. Detection of Chlamydia trachomatis in general practice urine samples. Br J Gen Pract. 1994 Mar;44(380):114–117. [PMC free article] [PubMed] [Google Scholar]
  13. Duthie S. J., Hobson D., Tait I. A., Pratt B. C., Lowe N., Sequeira P. J., Hargreaves C. Morbidity after termination of pregnancy in first trimester. Genitourin Med. 1987 Jun;63(3):182–187. doi: 10.1136/sti.63.3.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Evans B. G., Catchpole M. A., Heptonstall J., Mortimer J. Y., McCarrigle C. A., Nicoll A. G., Waight P., Gill O. N., Swan A. V. Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales. BMJ. 1993 Feb 13;306(6875):426–428. doi: 10.1136/bmj.306.6875.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. FESSLER A. Venereal disease and prostitution in the reports of the Poor Law Commissioners, 1834-1850. Br J Vener Dis. 1951 Sep;27(3):154–157. doi: 10.1136/sti.27.3.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fish A. N., Fairweather D. V., Oriel J. D., Ridgway G. L. Chlamydia trachomatis infection in a gynaecology clinic population: identification of high-risk groups and the value of contact tracing. Eur J Obstet Gynecol Reprod Biol. 1989 Apr;31(1):67–74. doi: 10.1016/0028-2243(89)90027-0. [DOI] [PubMed] [Google Scholar]
  17. Greco D., Giuliani M., Suligoi B., Panatta M., Giannetti A. Sexually transmitted diseases in Italy: clinical returns versus statutory notifications. Genitourin Med. 1990 Oct;66(5):383–386. doi: 10.1136/sti.66.5.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Groseclose S. L., Erickson B., Quinn T. C., Glasser D., Campbell C. H., Hook E. W., 3rd Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public sexually transmitted disease clinics. Sex Transm Dis. 1994 Jan-Feb;21(1):31–35. doi: 10.1097/00007435-199401000-00007. [DOI] [PubMed] [Google Scholar]
  19. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P., Changalucha J., Nicoll A., ka-Gina G. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995 Aug 26;346(8974):530–536. doi: 10.1016/s0140-6736(95)91380-7. [DOI] [PubMed] [Google Scholar]
  20. Hall L. A. "The Cinderella of medicine": sexually-transmitted diseases in Britain in the nineteenth and twentieth centuries. Genitourin Med. 1993 Aug;69(4):314–319. doi: 10.1136/sti.69.4.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hanenberg R. S., Rojanapithayakorn W., Kunasol P., Sokal D. C. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet. 1994 Jul 23;344(8917):243–245. doi: 10.1016/s0140-6736(94)93004-x. [DOI] [PubMed] [Google Scholar]
  22. Harms G., Matull R., Randrianasolo D., Andriamiadana J., Rasamindrakotroka A., Kirsch T., Hof U., Rarivoharilala E., Korte R. Pattern of sexually transmitted diseases in a Malagasy population. Sex Transm Dis. 1994 Nov-Dec;21(6):315–320. doi: 10.1097/00007435-199411000-00004. [DOI] [PubMed] [Google Scholar]
  23. Hayes R., Mosha F., Nicoll A., Grosskurth H., Newell J., Todd J., Killewo J., Rugemalila J., Mabey D. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design. AIDS. 1995 Aug;9(8):919–926. doi: 10.1097/00002030-199508000-00014. [DOI] [PubMed] [Google Scholar]
  24. Herrmann B. F., Johansson A. B., Mårdh P. A. A retrospective study of efforts to diagnose infections by Chlamydia trachomatis in a Swedish county. Sex Transm Dis. 1991 Oct-Dec;18(4):233–237. doi: 10.1097/00007435-199110000-00007. [DOI] [PubMed] [Google Scholar]
  25. Humphreys J. T., Henneberry J. F., Rickard R. S., Beebe J. L. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics. Sex Transm Dis. 1992 Jan-Feb;19(1):47–53. doi: 10.1097/00007435-199201000-00010. [DOI] [PubMed] [Google Scholar]
  26. Hunt A. J., Davies P. M., Weatherburn P., Coxon A. P., McManus T. J. Changes in sexual behaviour in a large cohort of homosexual men in England and Wales, 1988-9. BMJ. 1991 Mar 2;302(6775):505–506. doi: 10.1136/bmj.302.6775.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. KING A. These dying diseases; venerology in decline. Lancet. 1958 Mar 29;1(7022):651–657. doi: 10.1016/s0140-6736(58)91082-1. [DOI] [PubMed] [Google Scholar]
  28. Laga M., Plummer F. A., Piot P., Datta P., Namaara W., Ndinya-Achola J. O., Nzanze H., Maitha G., Ronald A. R., Pamba H. O. Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum. A comparison of silver nitrate and tetracycline. N Engl J Med. 1988 Mar 17;318(11):653–657. doi: 10.1056/NEJM198803173181101. [DOI] [PubMed] [Google Scholar]
  29. Lyons M. Sexually transmitted diseases in the history of Uganda. Genitourin Med. 1994 Apr;70(2):138–145. doi: 10.1136/sti.70.2.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lyttle P. H. Surveillance report: disease trends at New Zealand sexually transmitted disease clinics 1977-1993. Genitourin Med. 1994 Oct;70(5):329–335. doi: 10.1136/sti.70.5.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. MacDougall H. Sexually transmitted diseases in Canada, 1800-1992. Genitourin Med. 1994 Feb;70(1):56–63. doi: 10.1136/sti.70.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Marx R., Aral S. O., Rolfs R. T., Sterk C. E., Kahn J. G. Crack, sex, and STD. Sex Transm Dis. 1991 Apr-Jun;18(2):92–101. doi: 10.1097/00007435-199118020-00008. [DOI] [PubMed] [Google Scholar]
  33. Massé R., Laperrière H., Rousseau H., Lefebvre J., Remis R. S. Chlamydia trachomatis cervical infection: prevalence and determinants among women presenting for routine gynecologic examination. CMAJ. 1991 Oct 15;145(8):953–961. [PMC free article] [PubMed] [Google Scholar]
  34. Merson M. H. Slowing the spread of HIV: agenda for the 1990s. Science. 1993 May 28;260(5112):1266–1268. doi: 10.1126/science.8493570. [DOI] [PubMed] [Google Scholar]
  35. Moses S., Manji F., Bradley J. E., Nagelkerke N. J., Malisa M. A., Plummer F. A. Impact of user fees on attendance at a referral centre for sexually transmitted diseases in Kenya. Lancet. 1992 Aug 22;340(8817):463–466. doi: 10.1016/0140-6736(92)91778-7. [DOI] [PubMed] [Google Scholar]
  36. Oakley A., Fullerton D., Holland J., Arnold S., France-Dawson M., Kelley P., McGrellis S. Sexual health education interventions for young people: a methodological review. BMJ. 1995 Jan 21;310(6973):158–162. doi: 10.1136/bmj.310.6973.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Oakley A., Fullerton D., Holland J. Behavioural interventions for HIV/AIDS prevention. AIDS. 1995 May;9(5):479–486. [PubMed] [Google Scholar]
  38. Osoba A. O. Sexually transmitted diseases in tropical Africa. A review of the present situation. Br J Vener Dis. 1981 Apr;57(2):89–94. doi: 10.1136/sti.57.2.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. PEART A. F. W. The venereal disease problem in Canada. Can J Public Health. 1953 May;44(5):160–166. [PubMed] [Google Scholar]
  40. Piot P., Islam M. Q. Sexually transmitted diseases in the 1990s. Global epidemiology and challenges for control. Sex Transm Dis. 1994 Mar-Apr;21(2 Suppl):S7–13. [PubMed] [Google Scholar]
  41. Plorde D. S. Sexually transmitted diseases in Ethiopia. Social factors contributing to their spread and implications for developing countries. Br J Vener Dis. 1981 Dec;57(6):357–362. doi: 10.1136/sti.57.6.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Quinn T. C., Mann J. M., Curran J. W., Piot P. AIDS in Africa: an epidemiologic paradigm. Science. 1986 Nov 21;234(4779):955–963. doi: 10.1126/science.3022379. [DOI] [PubMed] [Google Scholar]
  43. Ramstedt K. M., Hallhagen G. J., Bygdeman S. M., Lincoln K. A., Kallings I., Gillenius C., Sandström E. G. Serologic classification and contact-tracing in the control of microepidemics of beta-lactamase-producing Neisseria gonorrhoeae. Sex Transm Dis. 1985 Oct-Dec;12(4):209–214. doi: 10.1097/00007435-198510000-00008. [DOI] [PubMed] [Google Scholar]
  44. Ramstedt K., Forssman L., Giesecke J., Granath F. Risk factors for Chlamydia trachomatis infection in 6810 young women attending family planning clinics. Int J STD AIDS. 1992 Mar-Apr;3(2):117–122. doi: 10.1177/095646249200300208. [DOI] [PubMed] [Google Scholar]
  45. Rothenberg R. B., Potterat J. J. Temporal and social aspects of gonorrhea transmission: the force of infectivity. Sex Transm Dis. 1988 Apr-Jun;15(2):88–92. doi: 10.1097/00007435-198804000-00004. [DOI] [PubMed] [Google Scholar]
  46. Rothenberg R. B. The geography of gonorrhea. Empirical demonstration of core group transmission. Am J Epidemiol. 1983 Jun;117(6):688–694. doi: 10.1093/oxfordjournals.aje.a113602. [DOI] [PubMed] [Google Scholar]
  47. Rothenberg R., Voigt R. Epidemiologic aspects of control of penicillinase-producing Neisseria gonorrhoeae. Sex Transm Dis. 1988 Oct-Dec;15(4):211–216. doi: 10.1097/00007435-198810000-00007. [DOI] [PubMed] [Google Scholar]
  48. Stall R. How to lose the fight against AIDS among gay men. BMJ. 1994 Sep 17;309(6956):685–686. doi: 10.1136/bmj.309.6956.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Stergachis A., Scholes D., Heidrich F. E., Sherer D. M., Holmes K. K., Stamm W. E. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol. 1993 Aug 1;138(3):143–153. doi: 10.1093/oxfordjournals.aje.a116840. [DOI] [PubMed] [Google Scholar]
  50. Suligoi B., Giuliani M., Binkin N. The national STD surveillance system in Italy: results of the first year of activity. STD Surveillance Working Group. Int J STD AIDS. 1994 Mar-Apr;5(2):93–100. doi: 10.1177/095646249400500203. [DOI] [PubMed] [Google Scholar]
  51. Thewessen E. A., van der Meijden W. I., Doppenberg H. J., Mulder P. G., Wagenvoort J. H., Stolz E., Michel M. F. Screening for cervical Chlamydia trachomatis infections in two Dutch populations. Genitourin Med. 1990 Oct;66(5):361–366. doi: 10.1136/sti.66.5.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Toomey K. E., Moran J. S., Rafferty M. P., Beckett G. A. Epidemiological considerations of sexually transmitted diseases in underserved populations. Infect Dis Clin North Am. 1993 Dec;7(4):739–752. [PubMed] [Google Scholar]
  53. Van Dyck E., Rossau R., Duhamel M., Behets F., Laga M., Nzila M., Bygdeman S., Van Heuverswijn H., Piot P. Antimicrobial susceptibility of Neisseria gonorrhoeae in Zaire: high level plasmid-mediated tetracycline resistance in central Africa. Genitourin Med. 1992 Apr;68(2):111–116. doi: 10.1136/sti.68.2.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Vieira J., Frank E., Spira T. J., Landesman S. H. Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants. N Engl J Med. 1983 Jan 20;308(3):125–129. doi: 10.1056/NEJM198301203080303. [DOI] [PubMed] [Google Scholar]
  55. Wasserheit J. N. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992 Mar-Apr;19(2):61–77. [PubMed] [Google Scholar]
  56. Weindling P. Sexually transmitted diseases between imperial and Nazi Germany. Genitourin Med. 1994 Aug;70(4):284–289. doi: 10.1136/sti.70.4.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wyke T. J. Hospital facilities for, and diagnosis and treatment of, venereal disease in England, 1800-1870. Br J Vener Dis. 1973 Feb;49(1):78–85. doi: 10.1136/sti.49.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Yorke J. A., Hethcote H. W., Nold A. Dynamics and control of the transmission of gonorrhea. Sex Transm Dis. 1978 Apr-Jun;5(2):51–56. doi: 10.1097/00007435-197804000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES